{{Rsnum
|rsid=10964862
|Chromosome=9
|position=21151554
|Orientation=plus
|GMAF=0.2998
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 16.8 | 42.5 | 40.7
| HCB | 3.6 | 26.3 | 70.1
| JPT | 1.8 | 28.6 | 69.6
| YRI | 13.7 | 45.2 | 41.1
| ASW | 19.3 | 45.6 | 35.1
| CHB | 3.6 | 26.3 | 70.1
| CHD | 2.8 | 33.6 | 63.6
| GIH | 16.0 | 46.0 | 38.0
| LWK | 10.0 | 54.5 | 35.5
| MEX | 10.5 | 42.1 | 47.4
| MKK | 9.0 | 41.0 | 50.0
| TSI | 6.9 | 44.6 | 48.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=20574843
|Title=Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations
|OA=1
}}

{{PMID Auto
|PMID=23209811
|Title=Influence of genetic variants in type I interferon genes on melanoma survival and therapy
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}